Intentar ORO - Gratis

Ireland Provides an Easy Market Into Europe

Bio Spectrum

|

December 2016

Sahajanand Medical Technologies (SMt) is developer and manufacturer of minimal-ly invasive coronary stent systems in India and supplies to around 60 countries in Europe, Asia, MENA and Latin America. the company has received numerous awards for its breakthrough innovations and quality, that have led to thinner and more flexible DES (drug-eluting stents) with good long term clinical results.

SMT is establishing its European headquarters, including Research, Development and Innovation centre in Ireland. We chat with SMt’s Western European Head, Gaurav Goel, to know more about it.

- Ayesha Siddiqui

Ireland Provides an Easy Market Into Europe

Gaurav Goel

Western European Head, Sahajanand Medical Technologies (SMT)

Q: What is the rationale behind setting up an office in Ireland?

A: Ireland is well known as the medical device hub of the world. 15 of the top 20 global medtech companies operate in Ireland. Ireland provides a complete eco-system in terms of infrastructure, highly skilled manpower, raw material and capital goods suppliers at close proximity. When SMT wanted to expand into the European market, it scouted various countries in Europe. The major thrust was to find out a suitable country where we could address our multiple requirements and Ireland was our answer. Ireland fits perfectly into our short term and long term goals. We look forward to bringing together our Indian talent along with the high skilled manpower available in Ireland to become a major global medical device player.

Q: Could you please throw some light on SMt’s product portfolio? What are your areas of focus as far as product services are concerned?

MÁS HISTORIAS DE Bio Spectrum

Bio Spectrum

Bio Spectrum

Building Breakthrough Medical Devices

Dr Ria Khurana founded RNT Health Insights, a Chandigarh-based healthtech startup specialising in Al-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, in 2022 along with Dr Tanmaya Gulati.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

Bridging classical epidemiology with modern science

A physician scientist with a MBBS from Lady Hardinge Medical College, (University of Delhi), a post-graduation in Paediatrics and a PhD from All India Institute of Medical Sciences (AIIMS), New Delhi, Prof.Shinjini Bhatnagar served as Professor of Eminence at Translational Health Science and Technology Institute (THSTI) until February 2023 and was subsequently appointed Distinguished Professor at THSTI until May 2025.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

"AI, Automation & Analytics: A new era of modern microbiology testing!"

Pharmaceutical manufacturing is undergoing a paradigm shift.

time to read

4 mins

January 2026

Bio Spectrum

Bio Spectrum

The CRISPR Moment

CRISPR (clustered regularly interspaced short palindromic repeats) technology is ushering in a new era of gene and cell therapy, offering more precision and potential for treating genetic disorders, cancer, and infectious diseases.

time to read

2 mins

January 2026

Bio Spectrum

Leveraging Microfluidic Technology for mRNA-LNP Manufacturing

Over the past five years, messenger RNA (mRNA) therapeutics have evolved from experimental concepts into lifesaving medicines.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

Demonstrating India's Vaccine Capabilities

Havisure is India's first and only indigenously developed Hepatitis A vaccine, to address one of the country's most persistent public health challengeswidespread Hepatitis A infections caused by inadequate sanitation and contaminated food and water.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

Inspiring Future Generations

A PhD in molecular biology from the University of Cambridge, UK, Prof. Gaiti Hasan is a Distinguished Fellow at the National Centre for Biological Sciences (NCBS), Bengaluru.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

A Landmark for India's Antibiotic Innovation

After three decades of research and hard work, India has led the way with the creation of Nafithromycin, the country's first indigenous antibiotic.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

"Future vaccine innovation will be integration of R&D, regulatory support and manufacturing”

TechInvention Lifecare Limited, a vaccine focused biotechnology company headquartered in Mumbai, is recognised for its innovative contributions to global healthcare.

time to read

4 mins

January 2026

Bio Spectrum

Bio Spectrum

Telangana: Building India's Most Credible Life Sciences Ecosystem

Telangana's recognition as BioSpectrum India's Best Performing State in Life Sciences 2025 is a timely validation of the direction the state has taken in recent years-one anchored in execution, responsiveness, and a clear understanding of where global life sciences value chains are headed.

time to read

4 mins

January 2026

Translate

Share

-
+

Change font size